Further evaluation of ZKN-157 across a panel of colorectal cancer–derived cell lines and patient-derived organoids identified that the consensus molecular subtype 2 (CMS2; refs. 12, 13) of colorectal cancer characterized by high MYC and WNT pathway activation is particularly sensitive to ZKN-157. This evidence concerns the gene MYC and colorectal cancer.